Skip to content

Comparison of Jacobson Relaxation Technique and Pranayama Technique in Patients With COPD

Comparison of Jacobson Relaxation Technique and Pranayama Technique in Patients With COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06463288
Enrollment
30
Registered
2024-06-17
Start date
2023-07-20
Completion date
2023-12-10
Last updated
2024-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Cough, Quality of Life, Shortness of Breath

Keywords

COPD, Jacobson Technique, Pranayama Technique, SOB

Brief summary

Comparison of Jacobson Relaxation Technique and Pranayama Technique in patients with COPD

Detailed description

Chronic obstructive pulmonary disease is a chronic inflammatory lung disease that cause obstructed airflow from the lungs. Symptoms include Breathing difficulty. cough, mucus production and wheezing. Its typically caused by long term exposure to irritating gasses or particulate matter, most often from cigarette smoker. in this study we compare the effect of Jacobson relaxation technique and Pranayama technique on the SOB, Cough, sputum and quality of life in COPD patients. Data were collected from Gulab Devi Chest Hospital, General Hospital, Jinnah Hospital and Mayo Hospital Lahore. Data were collected by the lottery method. Borg dyspnea scale, Spirometry, CASA-Q and Quality of life questionnaire were used before and after the intervention. Treatment was continuous 4 weeks, 3 times in a week for 15 mint. Assessment was done through the tool before and after the treatment.

Interventions

PROCEDUREJacobsons Breathing Technique

Quality of life, cough and sputum analysis, spirometry, and shortness of breath were assessed.

PROCEDUREPranayama Technique

Quality of life, cough and sputum analysis, spirometry, and shortness of breath were assessed.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single

Intervention model description

Randomized Clinical Trial

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* • Patients of Age between 40 and 70. * Both Genders (Male, Female) were included. * Stage 2 patient with COPD with Dyspnea FEV1 \<70% and Maximal Expiratory Pressure = 50% (Gold Criteria) were included. * Cognitive Stable patients were included. * Those Patients were included who were clinically stable without exacerbations in the past 01 month.

Exclusion criteria

* • Common Cough * Upper respiratory tract inflammation * Patients who have other co-morbid diseases which prevents them from exercise training, for example, disability due to neurological, orthopedic and acute cardiac causes * Patients who were mentally and physically and sick to join at the hospital or research site for training * Patients who were already participated or completed or in a P.R program in the past one year.

Design outcomes

Primary

MeasureTime frameDescription
Dyspnea Severity (Borg Scale)4 weeksThe Borg scale measures the severity of dyspnea (shortness of breath). Scale Details: Full Title: Borg Rating of Perceived Exertion (RPE) ScaleFull Title: Borg Rating of Perceived Exertion (RPE) Scale Minimum Value: 0 (No breathlessness at all) Maximum Value: 10 (Maximal breathlessness) Interpretation: Higher scores indicate worse outcomes, meaning greater severity of dyspnea.
Cough and Sputum Analysis (CASA-Q)4 WeeksThe CASA-Q (Cough and Sputum Assessment Questionnaire) evaluates the severity and impact of cough and sputum production. Scale Details: Full Title: Cough and Sputum Assessment Questionnaire (CASA-Q) Minimum Value: 0 (No symptoms) Maximum Value: 100 (Severe symptoms) Interpretation: Higher scores indicate worse outcomes, meaning more severe symptoms of cough and sputum.
Spirometry (FEV1 and FVC)4 WeeksSpirometry will be used to measure lung function, specifically Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC). Scale Details: Full Title: Spirometry (FEV1 and FVC) Minimum Value: Variable (dependent on patient's lung function) Maximum Value: Variable (dependent on patient's lung function) Interpretation: Higher values typically indicate better lung function.

Secondary

MeasureTime frameDescription
Quality of Life (SF-36 Questionnaire)4 WeeksThe SF-36 (Short Form Health Survey) questionnaire assesses the overall quality of life. Scale Details: Full Title: SF-36 Health Survey Minimum Value: 0 (Worst possible health state) Maximum Value: 100 (Best possible health state) Interpretation: Higher scores indicate better quality of life.
Patient Satisfaction (Patient Satisfaction Questionnaire)4 WeeksThe Patient Satisfaction Questionnaire measures the satisfaction of patients with the treatment they received. Full Title: Patient Satisfaction Questionnaire (PSQ) Minimum Value: 1 (Very dissatisfied) Maximum Value: 5 (Very satisfied) Interpretation: Higher scores indicate greater satisfaction.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026